AMR Stakeholder Profile
Focus area/active in: Human Health, Therapeutics, Diagnostics
Company/Organisation type: Accelerator | Finance | Investor
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global non-profit partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. The CARB-X portfolio is the world’s most diverse, early development pipeline of new antibiotics, vaccines, rapid diagnostics and other products to prevent, diagnose and treat life-threatening bacterial infections.
Get in touch!
Please fill out the form below to get in touch with us.